A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis
- 7 May 2020
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 137, 115406
- https://doi.org/10.1016/j.bone.2020.115406
Abstract
No abstract availableKeywords
Funding Information
- Seventh Framework Programme (602300)
- University of Antwerp (FFB190208)
This publication has 29 references indexed in Scilit:
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic ProfilingJournal of Clinical Oncology, 2011
- From basic research to clinical development of MEK1/2 inhibitors for cancer therapyJournal of Hematology & Oncology, 2010
- MEK1 mutations confer resistance to MEK and B-RAF inhibitionProceedings of the National Academy of Sciences of the United States of America, 2009
- Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudyBMC Medicine, 2009
- Noisy splicing, more than expression regulation, explains why some exons are subject to nonsense-mediated mRNA decayBMC Biology, 2009
- Kinetochore–microtubule interactions: the means to the endCurrent Opinion in Cell Biology, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003